Cover Image

Assessment of inflammatory bowel disease risk prior to commencing IL‐17 inhibitors: A cross sectional analysis of Irish practice

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Amy Long, Claire Quigley, Lisa Murphy, Susan O'Gorman
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	JEADV Clinical Practice
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Nascent Nasal Phenomenon
by: Amy Long, et al.
Published: (2025)

Attitudes and practices of inflammatory bowel disease patients towards skin cancer risk and sun protection
by: Maeve Herlihy, et al.
Published: (2024)

Letter to the editor in response to the article “To assess the attitudes of Irish patients attending a pigmented lesion clinic and healthcare staff employed in an academic hospital to biobanking, a quantitative study”
by: Claudine Howard‐James, et al.
Published: (2024)

How green are emollients?
by: A. Long, et al.
Published: (2024)

Robbing Peter to Pay Paul—An Exploration of the Cost to the State of Melanoma Attributable to Sunbed Use in Ireland and a Comparison to the Potential for Profitability of Sunbed Premises
by: Claire Quigley, et al.
Published: (2025)

Multisystem inflammatory syndrome in adult with features of Kawasaki disease
by: Li Wei Heng, et al.
Published: (2024)

Retinol Misinformation Is ‘Topical’ on Social Media: A Qualitative Analysis
by: Brian Nolan, et al.
Published: (2025)

Evolution of patient demographics, baseline clinical characteristics and outcomes in Phase 3 trials of biologics (TNFi, IL12/23i, IL17i, IL23i), PDE4i and TYK2i for psoriasis
by: Sara Peeters, et al.
Published: (2024)

Microcystic Adnexal Carcinoma: Insights and Challenges From Ireland
by: Amy Long, et al.
Published: (2025)

Mechanobullous form of epidermolysis bullosa acquisita: Insights into disease mechanisms as inferred by response to rituximab, but not to JAK inhibitors
by: L. Gueissaz, et al.
Published: (2024)

Malignant melanoma and spina bifida
by: Sarah O'Mahony, et al.
Published: (2024)

Therapeutic inertia in the management of patients with moderate to severe psoriasis: A systematic review of cross‐sectional studies
by: Jennifer Lavina Ngo, et al.
Published: (2024)

A cross‐sectional study on quality of life in adult indolent systemic mastocytosis and its association with cutaneous involvement
by: Eugenio Isoletta, et al.
Published: (2024)

Quality of life in patients with anogenital warts: A cross‐sectional study using the Dermatology Life Quality Index questionnaire
by: GC Sagar, et al.
Published: (2024)

Comment on ‘The Doctors' Perception of Skin Diseases in General Practice in Denmark, With Emphasis on Atopic Dermatitis—A Descriptive Study’—The Irish Experience
by: Anna Wolinska, et al.
Published: (2025)

The doctors' perception of skin diseases in general practice in Denmark, with emphasis on atopic dermatitis: A descriptive study
by: Anne Sofie Froelunde, et al.
Published: (2024)

Rosacea fulminans: An anti‐inflammatory‐based therapeutic approach
by: Gabi Handgretinger, et al.
Published: (2024)

The Pre‐Adolescent Skin Care Pandemic: The Risks of Social Media‐Driven Beauty Trends in Children
by: Li Jie Helena Yoo, et al.
Published: (2025)

The Complex Role of IL‐13 in Bullous Pemphigoid: New Insights From a Retrospective Cohort Study
by: Marwan Dawood, et al.
Published: (2025)

Incidence and geographic differences in keratinocyte carcinoma and Bowen's disease in office‐based dermatological practice between 2013 and 2022: A nationwide Danish registry‐based study
by: Johan Sieborg, et al.
Published: (2024)

Recalcitrant pityriasis rubra pilaris in a Middle Eastern patient and arguments for early anti‐IL‐23 targeting
by: Mohammed N. Al‐Abdulla, et al.
Published: (2024)

What lies beneath: A qualitative review of misinformation on vulval lichen sclerosus
by: Yixuan Goh, et al.
Published: (2024)

No need for a p value. Comments on analytical decisions in “Rosacea fulminas: An anti‐inflammatory‐based therapeutic approach”
by: Yung Gonzaga, et al.
Published: (2024)

A Reply to ‘Comment on “The Doctors' Perception of Skin Diseases in General Practice in Denmark, With Emphasis on Atopic Dermatitis—A Descriptive Study”—The Irish Experience’ by Wolinska et al. Dermatology Training in General Practice—A Pan‐European Challenge?
by: A. S. Frølunde, et al.
Published: (2025)

A practical guide to over‐the‐counter treatments for hyperpigmentation
by: Mustufa Jafry, et al.
Published: (2024)

Shady Dealings: A Qualitative Review of Internet‐Based Sunglasses‐Related Misinformation
by: A. M. O'Leary, et al.
Published: (2026)

Annular Hailey–Hailey disease
by: Ariane Fizazi, et al.
Published: (2024)

Sun protection knowledge, attitudes and practices: A Lebanese‐based survey
by: Divina Justina Hasbani, et al.
Published: (2024)

The Efficacy and Safety of Atenolol for Treatment of Infantile Hemangioma
by: Michelle Shi, et al.
Published: (2025)

Erdheim–Chester disease presenting with eruptive fibrous histiocytomas
by: Michael J. Martinez, et al.
Published: (2024)

Cutaneous manifestations of systemic diseases in Afro‐Caribbean skin
by: Nadège Cordel
Published: (2024)

The utility of layering systemic therapies in connective tissue diseases
by: Kezia Surjanto, et al.
Published: (2024)

Delayed Time to First Skin Cancer Among Hematopoietic Stem Cell Transplant Recipients With Chronic Cutaneous Graft‐Versus‐Host Disease
by: Amy J. Petty, et al.
Published: (2025)

Fatigue is associated with disease severity in adult patients with hidradenitis suppurativa
by: Astrid Chodziuk, et al.
Published: (2024)

Skin matrix meets immunomatrix—Implications for genetic and acquired diseases
by: Alexander Nyström, et al.
Published: (2024)

Role of interleukins in dermatology: Exploring the immune mechanisms in skin diseases
by: Alvaro Prados‐Carmona, et al.
Published: (2024)

Full‐body skin examination in screening for cutaneous malignancy: A focus on concealed sites and the practices of international dermatologists
by: James P. Pham, et al.
Published: (2024)

Chronic urticaria as a manifestation of multicentric Castleman disease treated with rituximab
by: Osorio‐Aragón I. Yolanda, et al.
Published: (2024)

REVEAL AD ‐ Prevalence of Moderate and Severe Atopic Dermatitis in Ireland: A Cross‐ Sectional, Real World Study of a Secondary Care Population
by: Oisín S. Gough, et al.
Published: (2026)

Patient's Perspective on the Impact of Psoriasis on Their Quality of Life After 1 Year of Tildrakizumab Treatment: Despite Clinical Improvement, Persistence of a Potential Mental Cicatricial Memory of the Disease
by: Ziad Reguiai, et al.
Published: (2025)